ARCHIVES

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

This article is from The Cancer Letter archive.

Vol. 33 No. 06 | February 16, 2007

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983

DCT Board Approves Concept of New Programs, Including “Task Order”

November 2, 1979

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007